The influence of CCL21 on lymphatic dissemination (compared with hematogenous) has not been investigated thus far, but CCL21 is also highly expressed in lymph nodes, and CCR7 inhibition results in suppression of breast cancer lymph node metastases, which implies similar pathways for lymphatic and hematogenous dissemination [10]. The gene discussed is CCR7; the disease is breast carcinoma.